文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut-liver axis.

作者信息

Han Hui, Jiang Yi, Wang Mengyu, Melaku Mebratu, Liu Lei, Zhao Yong, Everaert Nadia, Yi Bao, Zhang Hongfu

机构信息

State Key Laboratory of Animal Nutrition, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing, China.

Precision Livestock and Nutrition Unit, Gembloux Agro-Bio Tech, University of Liège, Gembloux, Belgium.

出版信息

Crit Rev Food Sci Nutr. 2023;63(12):1689-1706. doi: 10.1080/10408398.2021.1966738. Epub 2021 Aug 18.


DOI:10.1080/10408398.2021.1966738
PMID:34404276
Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders in humans, partly because it is closely related to metabolic disorders of the liver with increasing prevalence. NAFLD begins with hepatic lipid accumulation, which may cause inflammation and eventually lead to fibrosis in the liver. Numerous studies have demonstrated the close relationship between gut dysfunction (especially the gut microbiota and its metabolites) and the occurrence and progression of NAFLD. The bidirectional communication between the gut and liver, named the gut-liver axis, is mainly mediated by the metabolites derived from both the liver and gut through the biliary tract, portal vein, and systemic circulation. Herein, we review the effects of the gut-liver axis on the pathogenesis of NAFLD. We also comprehensively describe the potential molecular mechanisms from the perspective of the role of liver-derived metabolites and gut-related components in hepatic metabolism and inflammation and gut health, respectively. The study provides insights into the mechanisms underlying current summarizations that support the intricate interactions between a disordered gut and NAFLD and can provide novel strategies to lessen the prevalence and consequence of NAFLD.

摘要

相似文献

[1]
Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut-liver axis.

Crit Rev Food Sci Nutr. 2023

[2]
Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.

World J Gastroenterol. 2023-2-14

[3]
The Role of Gut-Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC.

Biomedicines. 2022-2-23

[4]
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.

Free Radic Biol Med. 2017-1

[5]
Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms.

Clin Nutr ESPEN. 2021-8

[6]
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications.

Front Cell Infect Microbiol. 2022

[7]
Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut-liver axis?

Am J Physiol Gastrointest Liver Physiol. 2021-4-1

[8]
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.

Biomolecules. 2021-12-31

[9]
Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective.

Life Sci. 2023-5-15

[10]
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?

Nutrients. 2019-11-19

引用本文的文献

[1]
Effects of Prebiotics Inulin and Oat β-Glucan on Colonic Architecture and Hepatic Proteome in Mice with Circadian-Disruption-Aggravated Metabolic Dysfunction-Associated Steatohepatitis.

Nutrients. 2025-7-7

[2]
MASLD development: From molecular pathogenesis toward therapeutic strategies.

Chin Med J (Engl). 2025-8-5

[3]
The role of the gut microbiota and its metabolites: a new predictor in diabetes and its complications.

Eur J Med Res. 2025-7-9

[4]
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics.

World J Hepatol. 2025-6-27

[5]
The multifaceted role of microbiota in liver cancer: pathogenesis, therapy, prognosis, and immunotherapy.

Front Immunol. 2025-6-16

[6]
Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease.

Front Pharmacol. 2025-6-9

[7]
Bovine colostrum-derived extracellular vesicles protect against non-alcoholic steatohepatitis by modulating gut microbiota and enhancing gut barrier function.

Curr Res Food Sci. 2025-3-25

[8]
Gut microbiota in the development and progression of chronic liver diseases: Gut microbiota-liver axis.

World J Hepatol. 2025-3-27

[9]
Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk.

Biomolecules. 2025-1-22

[10]
Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Molecules. 2024-11-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索